27824163|t|The role of P2X7 receptors in a rodent PCP - induced schizophrenia model
27824163|a|P2X7 receptors (P2X7Rs) are ligand-gated ion channels sensitive to extracellular ATP. Here we examined for the first time the role of P2X7R in an animal model of schizophrenia. Using the PCP induced schizophrenia model we show that both genetic deletion and pharmacological inhibition of P2X7Rs alleviate schizophrenia-like behavioral alterations. In P2rx7+/+ mice, PCP induced hyperlocomotion, stereotype behavior, ataxia and social withdrawal. In P2X7 receptor deficient mice (P2rx7-/-), the social interactions were increased, whereas the PCP induced hyperlocomotion and stereotype behavior were alleviated. The selective P2X7 receptor antagonist JNJ-47965567 partly replicated the effect of gene deficiency on PCP - induced behavioral changes and counteracted PCP - induced social withdrawal. We also show that PCP treatment upregulates and increases the functional responsiveness of P2X7Rs in the prefrontal cortex of young adult animals. The amplitude of NMDA evoked currents recorded from layer V pyramidal neurons of cortical slices were slightly decreased by both genetic deletion of P2rx7 and by JNJ-47965567. PCP induced alterations in mRNA expression encoding schizophrenia-related genes, such as NR2A, NR2B, neuregulin 1, NR1 and GABA α1 subunit were absent in the PFC of young adult P2rx7-/- animals. Our findings point to P2X7R as a potential therapeutic target in schizophrenia.
27824163	12	26	P2X7 receptors	T116,T192	C0386482
27824163	32	38	rodent	T015	C0035804
27824163	39	42	PCP	T109,T121	C0031381
27824163	45	52	induced	T169	C0205263
27824163	53	66	schizophrenia	T048	C0036341
27824163	67	72	model	T050	C0012644
27824163	73	87	P2X7 receptors	T116,T192	C0386482
27824163	89	95	P2X7Rs	T116,T192	C0386482
27824163	101	126	ligand-gated ion channels	T116,T123	C0815090
27824163	127	136	sensitive	T169	C0332324
27824163	140	153	extracellular	T026	C0521119
27824163	154	157	ATP	T114,T121,T123	C0001480
27824163	167	175	examined	T033	C0332128
27824163	207	212	P2X7R	T116,T192	C0386482
27824163	219	231	animal model	T008	C0599779
27824163	235	248	schizophrenia	T048	C0036341
27824163	260	263	PCP	T109,T121	C0031381
27824163	264	271	induced	T169	C0205263
27824163	272	285	schizophrenia	T048	C0036341
27824163	286	291	model	T050	C0012644
27824163	310	326	genetic deletion	T045	C1511760
27824163	331	346	pharmacological	T169	C0205464
27824163	347	357	inhibition	T052	C3463820
27824163	361	367	P2X7Rs	T116,T192	C0386482
27824163	368	377	alleviate	T169	C1301676
27824163	378	396	schizophrenia-like	T033	C0243095
27824163	397	407	behavioral	T053	C0004927
27824163	408	419	alterations	T078	C1515926
27824163	424	432	P2rx7+/+	T028	C1418215
27824163	433	437	mice	T015	C0025929
27824163	439	442	PCP	T109,T121	C0031381
27824163	443	450	induced	T169	C0205263
27824163	451	466	hyperlocomotion	T033	C3540840
27824163	468	487	stereotype behavior	T048	C0038271
27824163	489	495	ataxia	T184	C0004134
27824163	500	517	social withdrawal	T033	C0424095
27824163	522	535	P2X7 receptor	T028	C1418215
27824163	536	545	deficient	T169	C0011155
27824163	546	550	mice	T015	C0206745
27824163	552	560	P2rx7-/-	T028	C1418215
27824163	567	586	social interactions	T033	C0037420
27824163	592	601	increased	T081	C0205217
27824163	615	618	PCP	T109,T121	C0031381
27824163	619	626	induced	T169	C0205263
27824163	627	642	hyperlocomotion	T033	C3540840
27824163	647	666	stereotype behavior	T048	C0038271
27824163	672	682	alleviated	T169	C1301676
27824163	698	722	P2X7 receptor antagonist	T121	C2936582
27824163	723	735	JNJ-47965567	T121	C2936582
27824163	758	767	effect of	T080	C1280500
27824163	768	783	gene deficiency	T045	C1511760
27824163	787	790	PCP	T109,T121	C0031381
27824163	793	800	induced	T169	C0205263
27824163	801	819	behavioral changes	T055	C0542299
27824163	837	840	PCP	T109,T121	C0031381
27824163	843	850	induced	T169	C0205263
27824163	851	868	social withdrawal	T033	C0424095
27824163	888	891	PCP	T109,T121	C0031381
27824163	892	901	treatment	T169	C1522326
27824163	902	913	upregulates	T044	C0041904
27824163	918	927	increases	T169	C0442805
27824163	932	942	functional	T169	C0205245
27824163	943	957	responsiveness	T169	C0205342
27824163	961	967	P2X7Rs	T116,T192	C0386482
27824163	975	992	prefrontal cortex	T023	C0162783
27824163	996	1007	young adult	T100	C0238598
27824163	1008	1015	animals	T008	C0003062
27824163	1021	1030	amplitude	UnknownType	C0678555
27824163	1034	1038	NMDA	T116,T192	C0080093
27824163	1039	1045	evoked	T080	C1444748
27824163	1046	1054	currents	T070	C1705970
27824163	1069	1094	layer V pyramidal neurons	T025	C0206441
27824163	1098	1106	cortical	T023	C0007776
27824163	1128	1137	decreased	T081	C0205216
27824163	1146	1162	genetic deletion	T045	C1511760
27824163	1166	1171	P2rx7	T028	C1418215
27824163	1179	1191	JNJ-47965567	T121	C2936582
27824163	1193	1196	PCP	T109,T121	C0031381
27824163	1197	1204	induced	T169	C0205263
27824163	1205	1216	alterations	T078	C1515926
27824163	1220	1235	mRNA expression	T045	C1515670
27824163	1245	1266	schizophrenia-related	T048	C0036341
27824163	1267	1272	genes	T028	C0017337
27824163	1282	1286	NR2A	T028	C1415299
27824163	1288	1292	NR2B	T028	C1415300
27824163	1294	1306	neuregulin 1	T116,T126	C0626201
27824163	1308	1311	NR1	T192	C0914905
27824163	1316	1323	GABA α1	T116,T192	C1565610
27824163	1337	1343	absent	T169	C0332197
27824163	1358	1369	young adult	T100	C0238598
27824163	1370	1378	P2rx7-/-	T028	C1418215
27824163	1379	1386	animals	T050	C1517490
27824163	1392	1400	findings	T033	C0243095
27824163	1410	1415	P2X7R	T116,T192	C0386482
27824163	1421	1430	potential	T080	C3245505
27824163	1431	1442	therapeutic	T169	C0302350
27824163	1443	1449	target	T169	C1521840
27824163	1453	1466	schizophrenia	T048	C0036341